INM

INMED PHARMACEUTICALS INC

INM·457637700·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

INM (INMED PHARMACEUTICALS INC) is held by 4 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($30,293), UBS Group AG ($5,204), Virtu Financial LLC ($13). Net institutional sentiment: Mixed.

4
Holders
$35,512
Total Value
60% (5)
Consensus
3 buying - 2 selling
13F: Insider & Congress:
INM

Smart Money Verdict

View all
Held by 4 funds

Who's Trading

InsiderALADAR1 Capital Management, LLCBuy $2KJul 15, 2026
ActivistVOVivo Opportunity Fund Holdings, L.P.21.7%Jun 10, 2026
ActivistADADAR1 Capital Management, LLC24.1%Jun 5, 2026
ActivistSMSquadron Master Fund LP9.8%May 27, 2026
ActivistSASABBY MANAGEMENT, LLC9.9%Jan 20, 2026
ActivistATAdvisorShares Trust0.0%Apr 2, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
46,973$30,2930.0%+119.74%
30
Increased
8,068(+2040.0%)$5,2040.0%+115.23%
17
New
19,980$130.0%+119.74%
15
Unchanged
2$20.0%-51.66%
0
Exited
0(-100.0%)$13,5180.0%-30.91%
0
Exited
0(-100.0%)$12,6970.0%-30.91%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used